Skip to main content

GSA CAPITAL PARTNERS LLP

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1362033 LONDON, X0

Position in INO

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$291,512
-$169,718 QoQ
Shares Held
265,011
-0.0% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#16
of 101 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. INO ranks #110 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $291,512 265,011
2026-03-31 $461,230 265,075
2025-12-31 $800,100 459,828
2025-09-30 $1,036,863 443,104
2025-06-30 $333,050 163,260
2024-03-31 $1,110,108 79,979
2023-12-31 $1,936,229 3,796,529
2023-09-30 $115,809 296,948
2023-03-31 $82,224 100,274
2022-12-31 $249,724 160,080
2022-06-30 $67,046 38,755
2022-03-31 $348,373 97,040
2021-12-31 $274,235 54,957
2021-09-30 $242,681 33,894
2021-06-30 $219,754 23,706
2021-03-31 $227,972 24,566
2020-12-31 $167,176 18,890
2020-03-31 $204,227 27,450